Camp4 Therapeutics (CAMP) Invested Capital (2023 - 2025)
Historic Invested Capital for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $58.7 million.
- Camp4 Therapeutics' Invested Capital rose 13694.98% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 13694.98%. This contributed to the annual value of $63.3 million for FY2024, which is 15116.38% up from last year.
- As of Q3 2025, Camp4 Therapeutics' Invested Capital stood at $58.7 million, which was up 13694.98% from $40.1 million recorded in Q2 2025.
- Over the past 5 years, Camp4 Therapeutics' Invested Capital peaked at $63.3 million during Q4 2024, and registered a low of -$159.0 million during Q3 2024.
- For the 3-year period, Camp4 Therapeutics' Invested Capital averaged around -$25.8 million, with its median value being $40.1 million (2025).
- Over the last 5 years, Camp4 Therapeutics' Invested Capital had its largest YoY gain of 15116.38% in 2024, and its largest YoY loss of 4251.46% in 2024.
- Over the past 3 years, Camp4 Therapeutics' Invested Capital (Quarter) stood at -$123.7 million in 2023, then soared by 151.16% to $63.3 million in 2024, then decreased by 7.21% to $58.7 million in 2025.
- Its Invested Capital was $58.7 million in Q3 2025, compared to $40.1 million in Q2 2025 and $51.7 million in Q1 2025.